Approximately 20 million women worldwide have taken Depo-Provera, an injectable form of birth control produced by Pfizer. Women typically took these medroxyprogesterone acetate (MPA) or depot medroxyprogesterone acetate (DMPA) injections for contraceptive use:
Depo-Provera
Depo-subQ Provera 104
Recent studies have found that women who took the birth control shot are five times more likely to develop intracranial meningiomas, a type of brain tumor that affects the central nervous system.
If you were diagnosed with a brain tumor after taking MPA or DMPA injections for at least a year, you may be eligible for compensation. The attorneys of Bursor & Fisher, P.A. can help you take legal action.
A March 2024 study published in the British Medical Journal (BMJ) raised new concerns about the long-term effects of Depo-Provera use. The study found that medroxyprogesterone acetate (the primary progestin in Depo-Provera) made patients 555% more likely to develop intracranial meningiomas. While often benign and non-cancerous, these brain tumors can still cause issues with memory, speech, vision, and motor function.
While intracranial meningioma patients have a high survival rate, a brain tumor can have long-term repercussions even after successful treatment. The attorneys of Bursor & Fisher, P.A. are here to help. Our lawyers can help you explore your legal options during a free, no-obligation case evaluation. Any financial remedies you receive can cover your medical bills, lost wages, and changes to your quality of life.